Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2009
|
| gptkbp:focus |
gptkb:disease
immunology neuroscience oncology |
| gptkbp:foundedIn |
1976
|
| gptkbp:founder |
gptkb:Herbert_Boyer
gptkb:Robert_Swanson |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Genetech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableAchievement |
pioneer in recombinant DNA technology
first to produce synthetic human insulin |
| gptkbp:notableProduct |
gptkb:Activase
gptkb:Avastin gptkb:Herceptin gptkb:Rituxan |
| gptkbp:numberOfEmployees |
over 13,000
|
| gptkbp:parentCompany |
gptkb:Roche
|
| gptkbp:stockSymbol |
formerly DNA (NASDAQ)
|
| gptkbp:type |
gptkb:subsidiary
|
| gptkbp:website |
https://www.gene.com
|
| gptkbp:bfsParent |
gptkb:Psionex
|
| gptkbp:bfsLayer |
6
|